Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05714033
Other study ID # 2022-0756
Secondary ID NCI-2023-00783
Status Recruiting
Phase N/A
First received
Last updated
Start date February 10, 2023
Est. completion date September 14, 2032

Study information

Verified date April 2024
Source M.D. Anderson Cancer Center
Contact Roberto Casal, MD
Phone (832) 287-9479
Email rfcasal@mdanderson.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To learn if LADS is better than VESPA at preventing atelectasis during a robotic bronchoscopy.


Description:

Primary Objective: To compare the proportion of patients developing target-obscuring atelectasis when using a lateral decubitus strategy (LADS) vs using a ventilatory strategy to prevent atelectasis (VESPA) during robotic bronchoscopy for posteriorly-located peripheral lung lesions. Secondary Objectives: - To compare the proportion of patients with atelectasis in the target lobe in VESPA vs. LADS during robotic bronchoscopy. - To compare the proportion of patients with atelectasis obscuring 100%, 50% or more, and less than 50% of the target during robotic bronchoscopy using LADS vs. VESPA. - To compare the proportion of patients in whom a biopsy sample was not taken due to atelectasis using LADS vs. VESPA. - To compare the diagnostic yield using LADS vs. VESPA. - To compare the proportion of tool in lesion (TIL) using LADS vs. VESPA. - To compare the diagnostic accuracy (sensitivity and specificity) for malignancy using LADS vs. VESPA. - To compare the proportion of LADS-induced vs. VESPA-induced complications. - To compare the proportion of bronchoscopy-induced complications in LADS vs. VESPA.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date September 14, 2032
Est. primary completion date September 14, 2032
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Adult patients (= 18 years old) undergoing diagnostic robotic bronchoscopy for a lung nodule suspicious for malignancy bronchoscopy under general anesthesia. 2. Lung nodules should be up to 3 cm in diameter and located in right or left bronchial segments B2, B6, B9, and B10. Greater than 50% of the volume of the lesion needs to be below a horizontal line traced at the most anterior edge of the corresponding vertebral body. 3. Chest CT performed < 4 weeks prior to bronchoscopy. 4. Voluntary informed consent to participate in the study. Exclusion Criteria: 1. Patients with prior lung consolidation, interstitial changes or lung masses (> 3 cm in diameter) as seen on most recent CT 2. Lesions outside of the designated lung areas defined as inclusion criteria. 3. Known pregnancy 4. Vulnerable population 5. Ascites 6. Known diaphragmatic paralysis 7. Smokers or ex-smokers with known or suspected severe air-trapping defined as residual volume > 150% of predicted 8. History of primary or secondary spontaneous pneumothorax 9. Lung bullae > 5 cm 10. Patients with mediastinal or hilar adenopathy with high suspicion for malignancy in whom lymph node sampling is indicated and should occur prior to robotic bronchoscopy of the peripheral lesion. 11. Patient with active COVID pneumonia.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Ventilatory Strategy To Prevent Atelectasis
Given
Lateral Decubitus Strategy (LADS)
Given

Locations

Country Name City State
United States M D Anderson Cancer Center Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 through study completion; an average of 1 year.
See also
  Status Clinical Trial Phase
Completed NCT00026689 - Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols
Recruiting NCT05055739 - Comparative Study Between Sternal Closure With Sternalock® Blue Versus Steel Wire Submitted To Bilateral Anterior Transsternal Thoracotomy (Clamshell) For Bilateral Lung Transplant N/A
Not yet recruiting NCT04616820 - Endocan Blood Level in Pulmonary Circulation
Recruiting NCT02201446 - The Role of Circulating Soluble CD74 in Acute Lung Injury N/A
Completed NCT02833246 - Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications N/A
Recruiting NCT06115395 - Non-invasive Ventilation Assisted Fiber-optic Bronchoscopy N/A
Withdrawn NCT00588263 - Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer N/A
Completed NCT05268263 - Feasibility of AI-based Classification of Normal, Wheeze and Crackle Sounds From Stethoscope in Clinical Settings N/A
Active, not recruiting NCT02849041 - Screening of Tobacco-induced Cancers by Low-dose CT-scanner and Identification of Circulating Tumor Cells N/A
Recruiting NCT05050370 - A Brief SMART Exercise Instant Messaging Support Intervention - a Pilot Study N/A
Completed NCT00484016 - Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC N/A
Completed NCT00972205 - Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors N/A
Completed NCT02535013 - Intraoperative Lung Ultrasound in Pediatric Patients N/A

External Links